New Trial: MPD-115!

News

We are now recruiting subjects for the trial MPD-RC 115: Open label study of single agent oral RG7388 in patients with polycythemia vera and essential thrombocythemia, with pilot feasibility study in combination with pegylated interferon alfa 2a.

» 115 Protocol on ClinicalTrials.gov
superadmin on May 08 2015 10:09:03 · Print

MPD-109

News

We are now recruiting subjects for the trial MPD-RC 109: Combination Therapy of Ruxolitinib and Decitabine in patients with Myeloproliferative Neoplasms in Accelerated and Blast Phase Disease.

» 109 Protocol on ClinicalTrials.gov
superadmin on May 05 2014 11:31:46 · Print

MPD-114

News

We are now recruiting subjects for the trial MPD-RC 114: Exploring the Potential of Dual Kinase JAK 1/2 Inhibitor Ruxolitinib (INC424) with Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Patients with Myelofibrosis.

» 114 Protocol on ClinicalTrials.gov
superadmin on November 13 2013 10:00:11 · Print

MPD-111

News

We are recruiting patients to the study 111.

»111 Protocol on ClinicalTrials.gov
superadmin on October 27 2011 14:34:41 · Print

MPD-112

News

We are recruiting patients for the clinical trial 112.

»112 Protocol on ClinicalTrials.gov
superadmin on September 24 2011 00:00:00 · Print